Rejection of InterMune’s Drug Told Early to FDA Advisers

Rejection of InterMune’s Drug Told Early to FDA Advisers

Submitted by admin on December 26, 2012 - 9:23am
Source: 
Bloomberg
News Tags: 
FDA
InterMune
Esbriet
IPF
Headline: 
Rejection of InterMune’s Drug Told Early to FDA Advisers

Do Not Allow Advertisers to Use My Personal information